nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An abbreviated Caprini model for VTE risk assessment in trauma
|
Hazeltine, Max D. |
|
|
53 |
4 |
p. 878-886 |
artikel |
2 |
Antithrombotic strategy and its relationship with outcomes in patients with atrial fibrillation and chronic coronary syndrome
|
Lv, Wen-He |
|
|
53 |
4 |
p. 868-877 |
artikel |
3 |
Association of acidosis with coagulopathy and transfusion requirements in liver transplantation
|
de Souza, Júlia Ruete |
|
|
53 |
4 |
p. 887-897 |
artikel |
4 |
A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals who received COVID-19 adenoviral-vector-based vaccines
|
Elberry, Mostafa H. |
|
|
53 |
4 |
p. 798-823 |
artikel |
5 |
Barriers and motivators to national board certification as a certified anticoagulation care provider
|
Rudd, Kelly M. |
|
|
53 |
4 |
p. 761-765 |
artikel |
6 |
Characteristics and comparisons of acute stroke in “recovered" to “active COVID-19 and “pre-pandemic” in Qatar database
|
Akhtar, Naveed |
|
|
53 |
4 |
p. 824-828 |
artikel |
7 |
Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease
|
Gauchel, Nadine |
|
|
53 |
4 |
p. 788-797 |
artikel |
8 |
Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient
|
Jacobs, Jeremy W. |
|
|
53 |
4 |
p. 945-949 |
artikel |
9 |
Development and validation of an analytical method for the determination of direct oral anticoagulants (DOAC) and the direct thrombin-inhibitor argatroban by HPLC–MS/MS
|
Brückner, Lea |
|
|
53 |
4 |
p. 777-787 |
artikel |
10 |
Different patterns of white matter lesions among patent foramen ovale, atherosclerotic cerebral small vessel disease and cerebral venous thrombosis
|
Wu, Xiaoqin |
|
|
53 |
4 |
p. 911-925 |
artikel |
11 |
Efficacy outcomes and safety measures of intravenous tirofiban or eptifibatide for patients with acute ischemic stroke: a systematic review and meta-analysis of prospective studies
|
Liu, Jingting |
|
|
53 |
4 |
p. 898-910 |
artikel |
12 |
Eltrombopag for refractory vaccine-induced immune thrombotic thrombocytopenia
|
Maraziti, Giorgio |
|
|
53 |
4 |
p. 954-958 |
artikel |
13 |
Evaluation of heparin infusion rates in patients with intravenous drug misuse
|
Barga, Kenneth |
|
|
53 |
4 |
p. 959-964 |
artikel |
14 |
Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study—Reply to comment from Muzaffar et al.
|
Fan, Bingwen Eugene |
|
|
53 |
4 |
p. 976-978 |
artikel |
15 |
Incidence of thrombotic complications related to weight-based dosing of activated prothrombin complex concentrate (aPCC) for reversal of apixaban and rivaroxaban in obese patients
|
Whitaker, Caitlyn |
|
|
53 |
4 |
p. 861-867 |
artikel |
16 |
Initial assessment of α-synuclein structure in platelets
|
Stefaniuk, Catherine M. |
|
|
53 |
4 |
p. 950-953 |
artikel |
17 |
Italian experience with rVIII-single chain: a survey of patients with haemophilia A and their physicians
|
Borchiellini, Alessandra |
|
|
53 |
4 |
p. 934-944 |
artikel |
18 |
Novel multi-marker proteomics in phenotypically matched patients with ST-segment myocardial infarction: association with clinical outcomes
|
Shavadia, Jay S. |
|
|
53 |
4 |
p. 841-850 |
artikel |
19 |
Oral anticoagulation patterns and prognosis in octogenarian patients with atrial fibrillation
|
Papanastasiou, Anastasios |
|
|
53 |
4 |
p. 851-860 |
artikel |
20 |
REPLY to “Association Between Plasmatic Oxidative Stress and Thrombosis in Primary Antiphospholipid Syndrome”
|
Bucci, T. |
|
|
53 |
4 |
p. 974-975 |
artikel |
21 |
The long-term survival in patients with chronic thromboembolic pulmonary hypertension: experience from a single center in China
|
Hu, Song |
|
|
53 |
4 |
p. 926-933 |
artikel |
22 |
Thromboembolic events following mRNA vaccines for COVID 19: a case series
|
Serrao, Alessandra |
|
|
53 |
4 |
p. 971-973 |
artikel |
23 |
Thrombosis in VEXAS syndrome
|
Oo, Thet Mon |
|
|
53 |
4 |
p. 965-970 |
artikel |
24 |
Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study
|
Deitelzweig, Steve |
|
|
53 |
4 |
p. 766-776 |
artikel |
25 |
Ventilation/perfusion (V/Q) scanning in contemporary patients with pulmonary embolism: utilization rates and predictors of use in a multinational study
|
Bonnefoy, Pierre-Benoît |
|
|
53 |
4 |
p. 829-840 |
artikel |